Cartesian Therapeutics, Inc. Investment Income, Interest
Cartesian Therapeutics, Inc. (RNAC) reported Investment Income, Interest of $1.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- Cartesian Therapeutics, Inc. investment income, interest for the quarter ending 2026-06-30 was $1.10M, a 36.90% decline year-over-year.
- Cartesian Therapeutics, Inc. investment income, interest for the quarter ending 2026-03-31 was $1.03M, a 49.08% decline year-over-year.
- Cartesian Therapeutics, Inc. investment income, interest for the quarter ending 2025-06-30 was $1.75M.
- Cartesian Therapeutics, Inc. investment income, interest for the quarter ending 2025-03-31 was $2.02M.
- Cartesian Therapeutics, Inc. investment income, interest for fiscal 2025 was $6.58M, a 10.93% decline from fiscal 2024.
- Cartesian Therapeutics, Inc. investment income, interest for fiscal 2024 was $7.39M, a 48.79% increase from fiscal 2023.
- Cartesian Therapeutics, Inc. investment income, interest for fiscal 2023 was $4.96M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 12 month |
|---|---|---|---|
| 2026-06-30 | $1.10M 10-Q · filed 2026-08-06 | $2.13M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.03M 10-Q · filed 2026-04-30 | ||
| 2025-12-31 | $6.58M 10-K · filed 2026-03-09 | ||
| 2025-06-30 | $1.75M 10-Q · filed 2026-08-06 | $3.76M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $2.02M 10-Q · filed 2026-04-30 | ||
| 2024-12-31 | $7.39M 10-K · filed 2026-03-09 | ||
| 2023-12-31 | $4.96M 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |